Skip to main content
Premium Trial:

Request an Annual Quote

Agilent, OGT Expand Partnership to Include Oligonucleotide Microarrays, SureSelect Products

NEW YORK (GenomeWeb News) – Agilent Technologies and Oxford Gene Technology today announced an expansion of an existing agreement for the provision of oligonucleotide microarrays and SureSelect target enrichment products to OGT for next-generation sequencing.

The deal builds on a partnership between the two firms dating back to 2007 when Agilent provided OGT access to its microarray platform. The agreement also made Agilent the OEM supplier of OGT-designed microarrays and made OGT an Agilent certified service provider.

Last year, OGT was the first company to achieve Agilent High-Throughput Microarray Certified Service Provider.

Terms of the extension were not disclosed.

Agilent's SureSelect Target Enrichment System is an in-solution hybridization capture technology that was originally developed in collaboration with the Broad Institute.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.